🔗 Visit the ClinicalTrials.gov page for NCT02028442
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial Watch:: Oncolytic viruses for cancer therapy. | Oncoimmunology | 2014 | 1.22 |
| 2 | Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses. | Mol Ther Methods Clin Dev | 2016 | 0.86 |
| 3 | Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data. | Hum Gene Ther | 2015 | 0.83 |
| 4 | Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"? | Mol Ther Oncolytics | 2015 | 0.77 |
| 5 | Promising oncolytic agents for metastatic breast cancer treatment. | Oncolytic Virother | 2015 | 0.76 |
| 6 | Oncolytic virotherapy for urological cancers. | Nat Rev Urol | 2016 | 0.76 |
| 7 | Virotherapy: cancer gene therapy at last? | F1000Res | 2016 | 0.75 |